HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 198 filers reported holding HERON THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 2.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $300 | -75.6% | 291,300 | -72.5% | 0.00% | -50.0% |
| Q2 2023 | $1,229 | -28.7% | 1,059,100 | -7.2% | 0.00% | 0.0% |
| Q1 2023 | $1,723 | +111.2% | 1,140,836 | +249.4% | 0.00% | +100.0% |
| Q4 2022 | $816 | -100.0% | 326,500 | +100.8% | 0.00% | -66.7% |
| Q1 2021 | $2,636,000 | +31.9% | 162,600 | +20.6% | 0.00% | +50.0% |
| Q3 2020 | $1,998,000 | -43.4% | 134,800 | -43.8% | 0.00% | -33.3% |
| Q2 2020 | $3,527,000 | -71.4% | 239,800 | -77.2% | 0.00% | -75.0% |
| Q1 2020 | $12,349,000 | +190.3% | 1,051,892 | +481.2% | 0.01% | +300.0% |
| Q4 2019 | $4,254,000 | +134.9% | 181,000 | +85.8% | 0.00% | +50.0% |
| Q2 2019 | $1,811,000 | -57.3% | 97,400 | -27.4% | 0.00% | -50.0% |
| Q3 2018 | $4,244,000 | -72.2% | 134,100 | -65.8% | 0.00% | -50.0% |
| Q2 2018 | $15,249,000 | +956.0% | 392,500 | +391.9% | 0.01% | +300.0% |
| Q4 2017 | $1,444,000 | -3.7% | 79,800 | +65.9% | 0.00% | -33.3% |
| Q2 2015 | $1,499,000 | – | 48,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 21,288 | $250,000 | 19.87% |
| TANG CAPITAL MANAGEMENT LLC | 2,896,904 | $34,010,000 | 4.78% |
| PFM Health Sciences, LP | 2,481,917 | $29,138,000 | 2.39% |
| Iron Triangle Partners LP | 500,000 | $5,870,000 | 2.27% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 777,599 | $9,129,000 | 1.72% |
| Pekin Hardy Strauss, Inc. | 588,732 | $6,912,000 | 1.55% |
| First Light Asset Management, LLC | 691,400 | $8,117,000 | 1.39% |
| Congress Park Capital LLC | 111,045 | $1,304,000 | 1.18% |
| Mesirow Financial Investment Management, Inc. | 15,135 | $178,000 | 1.12% |
| Elk Creek Partners, LLC | 509,174 | $5,978,000 | 1.03% |